These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6150627)

  • 41. Cardioprotective effect of metipranolol on ischemic heart muscle.
    Gvozdják J; Gvozdjáková A; Kucharská J; Bada V
    Cardiology; 1989; 76(3):206-10. PubMed ID: 2570631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.
    Yusuf S; Sleight P; Rossi P; Ramsdale D; Peto R; Furze L; Sterry H; Pearson M; Motwani R; Parish S; Gray R; Bennett D; Bray C
    Circulation; 1983 Jun; 67(6 Pt 2):I32-41. PubMed ID: 6851037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secondary prevention of myocardial infarction in the elderly.
    Abrahamsen AM; Gundersen T; Rønnevik P
    Curr Med Res Opin; 1982; 7(Suppl 1):68-78. PubMed ID: 7105797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemodynamic effects of oral disopyramide in patients with acute myocardial infarction].
    Bassan R; Miqueloti P; de Souza MA; Luz FS
    Arq Bras Cardiol; 1982 Nov; 39(5):355-7. PubMed ID: 7186390
    [No Abstract]   [Full Text] [Related]  

  • 45. The Norwegian Multicenter Study of Timolol after Myocardial Infarction.
    Pedersen TR
    Circulation; 1983 Jun; 67(6 Pt 2):I49-53. PubMed ID: 6342838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Timolol prevention in acute myocardial infarct. A Norwegian multi-centre study].
    Andersen M
    Ugeskr Laeger; 1981; 143(34):2175-6. PubMed ID: 7025411
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect on mortality of metoprolol in acute myocardial infarction. A randomized double-blind trial (author's transl)].
    Hjalmarson A; Elmfeldt D; Herlitz J; Holmberg S; Málek I; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wihelmsson C
    MMW Munch Med Wochenschr; 1982 Jan; 124(1):32-45. PubMed ID: 6799780
    [No Abstract]   [Full Text] [Related]  

  • 49. Circadian variation of beat-to-beat QT interval variability in patients with prior myocardial infarction and the effect of beta-blocker therapy.
    Furukawa Y; Shimizu H; Hiromoto K; Kanemori T; Masuyama T; Ohyanagi M
    Pacing Clin Electrophysiol; 2006 May; 29(5):479-86. PubMed ID: 16689842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Renal excretion of kallikrein after water loading and administration of furosemide or the beta-adrenergic blocker, trimepranol. A study in patients with a kidney allotransplant].
    Stríbrná J; Bultasová H; Rotnáglová Z; Martínek V
    Cas Lek Cesk; 1981 Feb; 120(6):154-9. PubMed ID: 6111397
    [No Abstract]   [Full Text] [Related]  

  • 51. Göteborg Metoprolol Trial: design, patient characteristics and conduct.
    Herlitz J; Holmberg S; Pennert K; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L
    Am J Cardiol; 1984 Jun; 53(13):3D-8D. PubMed ID: 6731326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The importance of precordial ECG mapping in patients with anterior myocardial infarct].
    Málek I; Stanĕk V; Gebauerová M; Fabián J
    Cas Lek Cesk; 1988 Feb; 127(9):261-5. PubMed ID: 2896545
    [No Abstract]   [Full Text] [Related]  

  • 53. [Reduction of experimental acute myocardial infarction using nifedipine].
    Sant'Anna JR; Lucchese FA; Mattos EC; Wagner EM; Rodrigues R
    Arq Bras Cardiol; 1980 Mar; 34(3):197-201. PubMed ID: 7436777
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effect of beta-receptor blockers and cardiac glycosides on the heart rate, systolic blood pressure and ST interval in submaximal ergometer exertion].
    Schaller K; Lange S
    Z Gesamte Inn Med; 1982 Jan; 37(2):50-3. PubMed ID: 7080551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Timolol Myocardial Infarction Study: an evaluation of selected variables.
    Rodda BE
    Circulation; 1983 Jun; 67(6 Pt 2):I101-6. PubMed ID: 6342836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemodynamic effects of nicardipine in acute myocardial infarction.
    Silke B; Verma SP; Hafizullah M; Reynolds G; Frais MA; Jackson NC; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():29-34. PubMed ID: 6527977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Timolol reduces mortality and reinfarct in patients surviving an acute myocardial infarct. The Norwegian Multicenter Study Group].
    MMW Munch Med Wochenschr; 1981 May; 123(22):929-38. PubMed ID: 6787417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nifedipine in hypertension and heart failure.
    Murakami E; Takekoshi N; Matsui S; Murakami H
    Clin Ther; 1984; 6(2):205-36. PubMed ID: 6705014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C; Ambrosioni E;
    Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.
    Heller DA; Ahern FM; Kozak M
    Am Heart J; 2000 Oct; 140(4):663-71. PubMed ID: 11011343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.